Results 11 to 20 of about 2,823,581 (316)
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. [PDF]
PLoS ONE, 2015 This survey analyzes two national pharmacovigilance databases in order to determine the major adverse reactions observed with the use of cholinesterase inhibitors in dementia.
Thibault B Ali +4 more
doaj +2 more sources
Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
Neurology, 2021 Objective To investigate whether cholinesterase inhibitors (ChEIs) are associated with slower cognitive decline in Alzheimer dementia and decreased risk of severe dementia or death.
Hong Xu +5 more
semanticscholar +1 more source
Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias.
Ideggyógyászati Szemle, 2021 In aging societies, the morbidity and mortality of dementia is increasing at a significant rate, thereby imposing burden on healthcare, economy and the society as well.
N. Balázs, D. Bereczki, T. Kovács
semanticscholar +1 more source
In vitro inhibition of human blood cholinesterases and protection against chlorpyriphos (organophosphate) by weak anticholinesterase drugs [PDF]
المجلة العراقية للصيدلة, 2011 In vitro inhibition of human plasma and erythrocyte cholinesterase activities by the strong cholinesterase inhibitor chlorpyriphos (organophosphate) and the weak cholinesterase inhibitors (donepezil, metoclopramide, and diphenhydramine) in different ...
Ahmed A.J. Mahmood
doaj +1 more source
Cochrane Database of Systematic Reviews, 2021 BACKGROUND Dementia is a progressive syndrome characterised by deterioration in memory, thinking and behaviour, and by impaired ability to perform daily activities. Two classes of drug - cholinesterase inhibitors (donepezil, galantamine and rivastigmine)
C. Parsons +6 more
semanticscholar +1 more source
British medical journal, 2021 Objective To evaluate the association between the use of antipsychotic drugs and cholinesterase inhibitors and the risk of falls and fractures in elderly patients with major neurocognitive disorders. Design Self-controlled case series.
Grace Hsin-Min Wang +4 more
semanticscholar +1 more source
Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study. [PDF]
PLoS Medicine, 2009 BACKGROUND: Cholinesterase inhibitors are commonly used to treat dementia. These drugs enhance the effects of acetylcholine, and reports suggest they may precipitate bradycardia in some patients.
Laura Y Park-Wyllie +5 more
doaj +1 more source
Cholinesterase inhibitors for delirium [PDF]
Cochrane Database of Systematic Reviews, 2005 Delirium is now the preferred term to describe acute confusional states. It is experienced by 10 to 30% of all hospital inpatients. Delirium is potentially reversible and is related to several adverse outcomes, including increased hospital length of stay, poor functional status, persistent cognitive impairment, need for institutional care and probably ...
Ross Overshott +2 more
openaire +3 more sources
Association of cognitive enhancers and incident seizure risk in dementia: a population-based study
BMC Geriatrics, 2022 Background Although individuals with dementia have a high risk of developing seizures, whether seizures are associated with cholinesterase inhibitors, which are commonly prescribed to treat individuals with dementia, remains unknown.
Junghee Ha +5 more
doaj +1 more source
Molecules, 2022 As an important source of cholinesterase inhibitors, alkaloids in natural products have high potential value in terms of exerting pharmacological activities.
Pengfei Yu +8 more
doaj +1 more source